Search

Search Results

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2651

  PDF: 968

  HTML: 28

• Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

  Paolo Dapavo, Matteo Megna, Marina Talamonti

  09-08-2024

  https://doi.org/10.4081/dr.2024.9999

  1711

  PDF: 647

  HTML: 93

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  https://doi.org/10.4081/dr.2023.9824

  874

  PDF: 522

  HTML: 29
• 

  Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

  Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

  21-11-2022

  https://doi.org/10.4081/dr.2022.9492

  1678

  PDF: 670

  HTML: 84

• Treatment satisfaction among patients with psoriasis in Saudi Arabia

  Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

  15-04-2024

  https://doi.org/10.4081/dr.2024.9967

  1010

  PDF: 529

  HTML: 25

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  1120

  PDF: 624

  HTML: 26

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  963

  PDF: 508

  SUPPLEMENTARY MATERIAL: 136

  HTML: 13
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  1043

  PDF: 528

  HTML: 17
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2355

  PDF: 1389

  HTML: 98
• 

  Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

  Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

  14-03-2022

  https://doi.org/10.4081/dr.2022.9091

  2611

  PDF: 620

  HTML: 6
• 

  Late reaction to ustekinumab infusion

  Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

  e2

  09-09-2013

  https://doi.org/10.4081/dr.2013.e2

  3949

  PDF: 653

  HTML: 260
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1126

  PDF: 603

  HTML: 19
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  https://doi.org/10.4081/dr.2022.9566

  1922

  PDF: 710

  HTML: 27
• 

  Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

  Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

  17-03-2022

  https://doi.org/10.4081/dr.2022.9282

  1151

  PDF: 806

  HTML: 41

• Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

  Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

  06-12-2024

  https://doi.org/10.4081/dr.2024.10171

  1470

  PDF: 415

  HTML: 28
• 

  Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

  Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

  25-06-2020

  https://doi.org/10.4081/dr.2020.8642

  1335

  PDF: 739

  HTML: 3

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  779

  PDF: 446

  HTML: 15
• 

  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

  Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

  14-07-2022

  https://doi.org/10.4081/dr.2022.9516

  1615

  PDF: 707

  HTML: 18
• 

  Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

  Raghavendra KR, Bangaru H

  06-07-2022

  https://doi.org/10.4081/dr.2022.9525

  2114

  PDF: 524

  HTML: 61
• 

  Erythrodermic psoriasis treated with apremilast

  John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

  19-09-2016

  https://doi.org/10.4081/dr.2016.6599

  2103

  PDF: 950

  HTML: 598
• 

  Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

  Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

  21-11-2022

  https://doi.org/10.4081/dr.2022.9265

  1514

  PDF: 435

  HTML: 23

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  380

  PDF: 257

  HTML: 9
• 

  A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project

  Francesco Cusano, Francesca Sampogna, Alexandra Maria Giovanna Brunasso Vernetti, Stefano Stisi, Gilda Sandri, Giovanna Malara, Luigi Naldi, Michele Pellegrino, Giovanni Luigi Tripepi, Umberto di Luzio Paparatti, Concetto Paolo Agnusdei, Claudio Bonifati, Antonella Celano, Valeria Corazza, Federica D'Agostino, Rocco De Pasquale, Emilio Filippucci, Rosario Foti, Giovanna Galdo, Fabiana Gai, Giulia Ganzetti, Dario Graceffa, Mara Maccarone, Annamaria Mazzotta, Gennaro Melchionda, Francesca Molinaro, Franco Paoletti, Silvia Tonolo, Adriano Vercellone, Rosetta Vitetta, Cesare Massone, Gian Domenico Sebastiani

  26-09-2022

  https://doi.org/10.4081/dr.2022.9541

  1241

  PDF: 687

  HTML: 35

• Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

  Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

  04-02-2025

  https://doi.org/10.4081/dr.2025.10232

  491

  PDF: 288

  HTML: 6
• 

  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

  Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

  01-10-2018

  https://doi.org/10.4081/dr.2018.7859

  1937

  PDF: 1040

  HTML: 62